Search

ePlex® System resource center

Articles, publications, webinars, and more

Browse through a variety of resources and learn more about respiratory infections, bloodstream infections, and the ePlex® System, ePlex® BCID and ePlex® RP2 Panels*.

Respiratory infections

Bloodstream infections

You might be interested in

...
    ...

    Webinars

    How rapid diagnostics can supercharge antimicrobial stewardship programs
    How rapid diagnostics can supercharge antimicrobial stewardship programs

    Eric Wenzler, PharmD, BCPS, BCIDP, AAHIVP, Assistant Professor, University of Illinois, Chicago

    Laboratory analysis of the ePlex® Blood Culture Identification Panels for timelier diagnosis of Gram-Negative and Gram-Positive bacteremia
    Laboratory analysis of the ePlex® Blood Culture Identification Panels for timelier diagnosis of Gram-Negative and Gram-Positive bacteremia

    Sixto M. Leal Jr., MD, PhD, Director of Clinical Microbiology, University of Alabama at Birmingham and Todd McCarty, MD, Infectious Diseases Physician, University of Alabama at Birmingham

    The impact of a rapid blood culture identification system on a pediatric institution
    The impact of a rapid blood culture identification system on a pediatric institution

    Joel E. Mortensen, PhD, Director of the Diagnostic Infectious Diseases Testing Laboratories, Cincinnati Children's Hospital

    Rapid BCID saved costs and reduced healthcare worker-patient interaction time during the COVID-19 pandemic
    Rapid BCID saved costs and reduced healthcare worker-patient interaction time during the COVID-19 pandemic

    Breida Boyle, MB.B.Ch.B.A.O, FRCPI, FRCPath(UK), FFPath(RCPI), PG  Dip. HIC (UK), Consultant Microbiologist, St. James Hospital, Department of Clinical Microbiology, Trinity College Dublin

    Implementation, impact, and updating of rapid blood culture identification system in a community hospital network
    Implementation, impact, and updating of rapid blood culture identification system in a community hospital network

    Kevin M. McNabb, Ph.D., MT, Director of Microbiology, Immunology and Molecular testing, New Hanover Medical Center

    ...
      ...

      You might be interested in

      ...
        ...

        * This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2 and multiple respiratory viral and bacterial organisms and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

        Some products in the above articles, publications, webinars and more may be referenced as investigational or research use only and now are IVD.